Cellebrite DI Ltd. (CLBT)
Technology • Software - Infrastructure
StockNasdaqGSIsraelIL0011794802
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Cellebrite DI Ltd., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 10:55. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 12 Nov 2026 07:00 | 0.16 | 0.17 | +7.5% | Beat |
| 13 Aug 2026 08:00 | 0.11 | — | — | — |
| 14 May 2026 07:00 | 0.10 | 0.12 | +24.0% | Beat |
| 11 Feb 2026 07:00 | 0.14 | 0.14 | +0.5% | In line |
| 12 Nov 2025 16:00 | 0.13 | 0.14 | +8.5% | Beat |
| 14 Aug 2025 07:00 | 0.11 | 0.12 | +12.2% | Beat |
| 14 May 2025 07:00 | 0.09 | 0.10 | +17.3% | Beat |
| 13 Feb 2025 07:00 | 0.10 | 0.10 | +0.6% | In line |
| 06 Nov 2024 07:00 | 0.09 | 0.14 | +58.1% | Beat |
| 15 Aug 2024 07:00 | 0.05 | 0.10 | +91.9% | Beat |
| 23 May 2024 07:00 | 0.06 | 0.08 | +42.0% | Beat |
| 15 Feb 2024 07:00 | 0.06 | 0.12 | +107.5% | Beat |
| 14 Nov 2023 07:00 | 0.05 | 0.09 | +90.0% | Beat |
| 08 Aug 2023 07:00 | 0.02 | 0.05 | +110.6% | Beat |
| 10 May 2023 07:00 | 0.02 | 0.03 | +36.4% | Beat |
| 15 Feb 2023 07:00 | 0.07 | 0.08 | +20.9% | Beat |
| 17 Nov 2022 07:00 | 0.02 | 0.01 | -54.1% | Miss |
| 11 Aug 2022 07:00 | 0.03 | — | -100.4% | — |
| 12 May 2022 07:00 | 0.02 | 0.01 | -55.6% | Miss |
| 16 Feb 2022 07:00 | 0.02 | 0.03 | +33.3% | Beat |
| 10 Nov 2021 07:00 | 0.02 | 0.08 | +300.0% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 475.7M | +18.6% | 78.3M | 16.5% | 0.31 | +123.0% | 160.3M |
| 2024 | 401.2M | +23.4% | -283M | -70.5% | -1.35 | -214.0% | 121.6M |
| 2023 | 325.1M | +20.1% | -81.1M | -24.9% | -0.43 | -172.9% | 94.1M |
| 2022 | 270.7M | — | 120.8M | 44.6% | 0.59 | — | 11.5M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 13.37 | 13.65 | 10.88 | 10.89 | -14.25% | 6,495,600 | |
| 11 Nov 2026 | 12.46 | 12.89 | 12.46 | 12.70 | +0.47% | 3,035,900 | |
| 10 Nov 2026 | 12.60 | 12.87 | 12.41 | 12.64 | -0.47% | 3,071,500 | |
| 09 Nov 2026 | 12.54 | 12.84 | 12.45 | 12.70 | +2.01% | 1,677,000 | |
| 06 Nov 2026 | 12.34 | 12.51 | 12.18 | 12.45 | +0.57% | 1,605,300 | |
| 05 Nov 2026 | 12.36 | 12.61 | 12.13 | 12.38 | -0.40% | 2,301,800 | |
| 04 Nov 2026 | 12.27 | 12.61 | 12.21 | 12.43 | +1.47% | 1,811,600 | |
| 03 Nov 2026 | 12.00 | 12.29 | 11.80 | 12.25 | +0.99% | 1,400,400 | |
| 02 Nov 2026 | 12.11 | 12.34 | 12.07 | 12.13 | -0.16% | 1,587,800 | |
| 30 Oct 2026 | 12.24 | 12.27 | 12.01 | 12.15 | -1.06% | 1,741,400 | |
| 1,249 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Cellebrite (CLBT) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 13 Nov 2026 00:29
- Cellebrite DI Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 12 Nov 2026 17:15
- Cellebrite DI Ltd. (CLBT) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 12 Nov 2026 15:49
- Cellebrite DI Ltd (NASDAQ:CLBT) Q3 Results: Revenue In Line, EPS Beat Supports Premarket Gain (opens in a new tab) ChartMill · 12 Nov 2026 13:23
- Cellebrite DI Ltd. (CLBT) Q3 Earnings Meet Estimates (opens in a new tab) Zacks · 12 Nov 2026 12:35
- Cellebrite DI Lowers FY2026 Sales Guidance from $555.000M-$561.000M to $553.000M-$558.000M vs $556.733M Est (opens in a new tab) Benzinga · 12 Nov 2026 08:02
- Cellebrite DI Q3 Adj. EPS $0.17 Beats $0.16 Estimate, Sales $149.022M Beat $145.923M Estimate (opens in a new tab) Benzinga · 12 Nov 2026 08:02
- Cellebrite DI Sees Q4 Sales $145.000M-$150.000M vs $151.451M Est (opens in a new tab) Benzinga · 12 Nov 2026 08:02
- Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026 (opens in a new tab) 09 Nov 2026 13:30
- Cellebrite Appoints Rogerio Rizzi Executive Vice President of Corporate Strategy and Development (opens in a new tab) 05 Nov 2026 13:30
- Cellebrite's 2026 Outlook: Subscription Pivot Weighs on the Stock Today, Helps Lead a Future Rebound (opens in a new tab) Motley Fool · 29 Sep 2026 18:50
- Is Cellebrite DI (CLBT) A Bargain On Its Subscription Growth Narrative? (opens in a new tab) Simply Wall St. · 22 Sep 2026 10:15
- Cellebrite (CLBT): CEO Shift and Guidance Cuts Contrast With Surging AI and FedRAMP Gains (opens in a new tab) Insider Monkey · 21 Aug 2026 22:12
- Cellebrite (CLBT) Q2 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 20 Aug 2026 14:43
- Cellebrite’s (CLBT) Compounding Track Record Demands Enterprise Software Re-Rating (opens in a new tab) Insider Monkey · 18 Aug 2026 12:50
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 12.70 USD
- Market cap
- 2.7B
- Exchange
- NasdaqGS
- Country
- Israel
- Sector
- Technology
- Industry
- Software - Infrastructure
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow CLBT and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.